Metallothioneins and zinc in cancer diagnosis and therapy

References

• Abdel-Mageed, A. B., Agrawal, K. C. (1998). Activation of nuclear factor kappa B: potential role in metallothionein-mediated mitogenic response. Cancer Res 58:2335–2338.
   PubMed Web of Science ®Google Scholar
• Abdel-Mageed, A. B., Zhao, F. S., Rider, B. J., Agrawal, K. C. (2003). Erythropoietin-induced metallothionein gene expression: role in proliferation of K562 cells. Exp Biol Med 228:1033–1039.
   Web of Science ®Google Scholar
• Abdelmageed, A. B., Agrawal, K. C. (1997). Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther 4:199–207.
   PubMed Web of Science ®Google Scholar
• Adam, V., Blastik, O., Krizkova, S., Lubal, P., Kukacka, J., Prusa, R., et al. (2008). Application of the Brdicka reaction in determination of metallothionein in patients with tumours. Chem Listy 102:51–58.
   Web of Science ®Google Scholar
• Adam, V., Fabrik, I., Eckschlager, T., Stiborova, M., Trnkova, L., Kizek, R. (2010). Vertebrate metallothioneins as target molecules for analytical techniques. TRAC-Trends Anal Chem 29:409–418.
   Web of Science ®Google Scholar
• Ames, B. N. (2001). DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 475:7–20.
   PubMed Web of Science ®Google Scholar
• Apostolova, M. D., Chen, S. L., Chakrabarti, S., Cherian, M. G. (2001). High-glucose-induced metallothionein expression in endothelial cells: an endothelin-mediated mechanism. Am J Physiol Cell Physiol 281:C899–C907.
   PubMed Web of Science ®Google Scholar
• Apostolova, M. D., Cherian, M. G. (2000). Delay of M-phase onset by aphidicolin can retain the nuclear localization of zinc and metallothionein in 3T3-L1 fibroblasts. J Cell Physiol 183:247–253.
   PubMed Web of Science ®Google Scholar
• Arriaga, J. M., Levy, E. M., Bravo, A. I., Bayo, S. M., Amat, M., Aris, M., et al. (2012). Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival. Hum Pathol 43:197–208.
   PubMed Web of Science ®Google Scholar
• Ba, L. A., Doering, M., Burkholz, T., Jacob, C. (2009). Metal trafficking: from maintaining the metal homeostasis to future drug design. Metallomics 1:292–311.
   PubMed Web of Science ®Google Scholar
• Babula, P., Kohoutkova, V., Opatrilova, R., Dankova, I., Masarik, M., Kizek, R. (2011). Pharmaceutical importance of zinc and metallothionein in cell signalling. Chim Oggi Chem Today 28:18–21.
   Web of Science ®Google Scholar
• Bagheri, P. M., Govaerts, I., De Ley, M. (2011). Role of metallothionein in differentiation of leukemia cells. Mol Biol Rep 38:3017–3022.
   PubMed Web of Science ®Google Scholar
• Baird, S. K., Kurz, T., Brunk, U. T. (2006). Metallothionein protects against oxidative stress-induced lysosomal destabilization. Biochem J 394:275–283.
   PubMed Web of Science ®Google Scholar
• Banerjee, D., Onosaka, S., Cherian, M. G. (1982). Immunohistochemical localization of metallothionein in cell-nucleus and cytoplasm of rat-liver and kidney. Toxicology 24:95–105.
   PubMed Web of Science ®Google Scholar
• Berendji, D., Kolbbachofen, V., Meyer, K. L., Grapenthin, O., Weber, H., Wahn, V., et al. (1997). Nitric oxide mediates intracytoplasmic and intranuclear zinc release. FEBS Lett 405:37–41.
   PubMed Web of Science ®Google Scholar
• Beyersmann, D., Hartwig, A. (2008). Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch Toxicol 82:493–512.
   PubMed Web of Science ®Google Scholar
• Binet, M. R. B., Cruz-Ramos, H., Laver, J., Hughes, M. N., Poole, R. K. (2002). Nitric oxide releases intracellular zinc from prokaryotic metallothionein in Escherichia coli. FEMS Microbiol Lett 213:121–126.
   PubMed Web of Science ®Google Scholar
• Bofill, R., Capdevila, M., Atrian, S. (2009). Independent metal-binding features of recombinant metallothioneins convergently draw a step gradation between Zn- and Cu-thioneins. Metallomics 1:229–234.
   PubMed Web of Science ®Google Scholar
• Borghesi, L. A., Lynes, M. A. (1996). Nonprotective effects of extracellular metallothionein. Toxicol Appl Pharmacol 139:6–14.
   PubMed Web of Science ®Google Scholar
• Borghesi, L. A., Youn, J., Olson, E. A., Lynes, M. A. (1996). Interactions of metallothionein with murine lymphocytes: plasma membrane binding and proliferation. Toxicology 108:129–140.
   PubMed Web of Science ®Google Scholar
• Boulikas, T., Vougiouka, M. (2003). Cisplatin and platinum drugs at the molecular level. (Review). Oncol Rep 10:1663–1682.
   PubMed Web of Science ®Google Scholar
• Bredel, M. (2001). Anticancer drug resistance in primary human brain tumors. Brain Res Rev 35:161–204.
   PubMed Web of Science ®Google Scholar
• Brewer, G. J. (2009). Zinc and tetrathiomolybdate for the treatment of Wilson’s disease and the potential efficacy of anticopper therapy in a wide variety of diseases. Metallomics 1:199–206.
   PubMed Web of Science ®Google Scholar
• Butcher, H. L., Kennette, W. A., Collins, O., Zalups, R. K., Koropatnick, J. (2004). Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts. J Pharmacol Exp Ther 310:589–598.
   PubMed Web of Science ®Google Scholar
• Cai, L., Satoh, M., Tohyama, C., Cherian, M. G. (1999). Metallothionein in radiation exposure: its induction and protective role. Toxicology 132:85–98.
   PubMed Web of Science ®Google Scholar
• Canogauci, D. F., Sarkar, B. (1996). Reversible zinc exchange between metallothionein and the estrogen receptor zinc finger. FEBS Lett 386:1–4.
   PubMed Web of Science ®Google Scholar
• Capdevila, M., Bofill, R., Palacios, O., Atrian, S. (2012). State-of-the-art of metallothioneins at the beginning of the 21st century. Coord Chem Rev 256:46–62.
   Web of Science ®Google Scholar
• Cardoso, S. V., Silveira, J. B., Machado, V. D., De-Paula, A. M. B., Loyola, A. M., De Aguiar, M. C. F. (2009). Expression of metallothionein and p53 antigens are correlated in oral squamous cell carcinoma. Anticancer Res 29:1189–1193.
   PubMed Web of Science ®Google Scholar
• Chakraborty, T., Chatterjee, A., Rana, A., Srivastawa, S., Damodaran, S., Chatterjee, M. (2007). Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression. Life Sci 81:489–499.
   PubMed Web of Science ®Google Scholar
• Chao, C. C. K. (1996). Molecular basis of cis-diamminedichloroplatinum(II) resistance: a review. J Formos Med Assoc 95:893–900.
   PubMed Web of Science ®Google Scholar
• Chen, M. D., Song, Y. M. (2009). Tissue metallothionein concentrations in mice and humans with hyperglycemia. Biol Trace Elem Res 127:251–256.
   PubMed Web of Science ®Google Scholar
• Chen, W. Y., John, J. A., Lin, C. H., Chang, C. Y. (2007). Expression pattern of metallothionein, MTF-1 nuclear translocation, and its DNA-binding activity in zebrafish (Danio rerio) induced by zinc and cadmium. Environ Toxicol Chem 26:110–117.
   PubMed Web of Science ®Google Scholar
• Chen, W. Y., John, J. A., Lin, C. H., Lin, H. F., Wu, S. C., Chang, C. Y. (2004). Expression of metallothionein gene during embryonic and early larval development in zebrafish. Aquat Toxicol 69:215–227.
   PubMed Web of Science ®Google Scholar
• Cherian, M. G., Apostolova, M. D. (2000). Nuclear localization of metallothionein during cell proliferation and differentiation. Cell Mol Biol 46:347–356.
   PubMed Web of Science ®Google Scholar
• Cherian, M. G., Jayasurya, A., Bay, B. H. (2003). Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 533:201–209.
   PubMed Web of Science ®Google Scholar
• Chiaverini, N., De Ley, M. (2010). Protective effect of metallothionein on oxidative stress-induced DNA damage. Free Radic Res 44:605–613.
   PubMed Web of Science ®Google Scholar
• Chong, C. R., Auld, D. S. (2007). Catalysis of zinc transfer by D-penicillamine to secondary chelators. J Med Chem 50:5524–5527.
   PubMed Web of Science ®Google Scholar
• Chubatsu, L. S., Meneghini, R. (1993). Metallothionein protects DNA from oxidative damage. Biochem J 291:193–198.
   PubMed Web of Science ®Google Scholar
• Coleman, J. E. (1992). Zinc proteins—enzymes, storage proteins, transcription factors, and replication proteins. Annu Rev Biochem 61:897–946.
   PubMed Web of Science ®Google Scholar
• Colvin, R. A., Holmes, W. R., Fontaine, C. P., Maret, W. (2010). Cytosolic zinc buffering and muffling: their role in intracellular zinc homeostasis. Metallomics 2:306–317.
   PubMed Web of Science ®Google Scholar
• Coyle, P., Philcox, J. C., Carey, L. C., Rofe, A. M. (2002). Metallothionein: the multipurpose protein. Cell Mol Life Sci 59:627–647.
   PubMed Web of Science ®Google Scholar
• Crowthers, K. C., Kline, V., Giardina, C., Lynes, M. A. (2000). Augmented humoral immune function in metallothionein-null mice. Toxicol Appl Pharmacol 166:161–172.
   PubMed Web of Science ®Google Scholar
• Cui, Y. P., Wang, J. B., Zhang, X. Y., Lang, R. G., Bi, M. X., Guo, L. P., et al. (2003). ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis. Biochem Biophys Res Commun 302:904–915.
   PubMed Web of Science ®Google Scholar
• Culotta, V. C., Hamer, D. H. (1989). Fine mapping of a mouse metallothionein gene metal response element. Mol Cell Biol 9:1376–1380.
   PubMed Web of Science ®Google Scholar
• Cummings, J. E., Kovacic, J. P. (2009). The ubiquitous role of zinc in health and disease. J Vet Emerg Crit Care 19:215–240.
   PubMed Web of Science ®Google Scholar
• Dhawan, D. K., Chadha, V. D. (2010). Zinc: a promising agent in dietary chemoprevention of cancer. Indian J Med Res 132:676–682.
   PubMed Web of Science ®Google Scholar
• Ding, Z. C., Ni, F. Y., Huang, Z. X. (2010). Neuronal growth-inhibitory factor (metallothionein-3): structure-function relationships. FEBS J, 277:2912–2920.
   PubMed Web of Science ®Google Scholar
• Dutsch-Wicherek, M. (2010). RCAS1, MT, and Vimentin as potential markers of tumor microenvironment remodeling. Am J Reprod Immunol 63:181–188.
   PubMed Web of Science ®Google Scholar
• Dutsch-Wicherek, M., Sikora, J., Tomaszewska, R. (2008). The possible biological role of metallothionein in apoptosis. Front Biosci 13:4029–4038.
   PubMed Web of Science ®Google Scholar
• Ebadi, M., Elsayed, M. A., Aly, M. H. M. (1993). Actions and regulation of protein-kinase-C in brain. Neuroendocrinol Lett 15:69–88.
   Web of Science ®Google Scholar
• Eckschlager, T., Adam, V., Hrabeta, J., Figova, K., Kizek, R. (2009). Metallothioneins and cancer. Curr Protein Pept Sci 10:360–375.
   Google Scholar
• Eide, D. J. (2011). The oxidative stress of zinc deficiency. Metallomics 3:1124–1129.
   PubMed Web of Science ®Google Scholar
• Ejnik, J., Munoz, A., Gan, T., Shaw, C. F., Petering, D. H. (1999). Interprotein metal ion exchange between cadmium-carbonic anhydrase and apo- or zinc-metallothionein. J Biol Inorg Chem 4:784–790.
   PubMed Web of Science ®Google Scholar
• El Sharkawy, S. L., Abbas, N. F., Badawi, M. A., El Shaer, M. A. (2006). Metallothionein isoform II expression in hyperplastic, dysplastic, and neoplastic prostatic lesions. J Clin Pathol 59:1171–1174.
   PubMed Web of Science ®Google Scholar
• Faller, P. (2010). Neuronal growth-inhibitory factor (metallothionein-3): reactivity and structure of metal-thiolate clusters. FEBS J 277:2921–2930.
   PubMed Web of Science ®Google Scholar
• Faller, W. J., Rafferty, M., Hegarty, S., Gremel, G., Ryan, D., Fraga, M. F., et al. (2010). Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosis. Melanoma Res 20:392–400.
   PubMed Web of Science ®Google Scholar
• Fan, L. Z., Cherian, M. G. (2002). Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. Br J Cancer 87:1019–1026.
   PubMed Web of Science ®Google Scholar
• Fang, Y. Z., Yang, S., Wu, G. Y. (2002). Free radicals, antioxidants, and nutrition. Nutrition 18:872–879.
   PubMed Web of Science ®Google Scholar
• Feng, W., Cai, J., Pierce, W. M., Franklin, R. B., Maret, W., Benz, F. W., et al. (2005). Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse hearts. Biochem Biophys Res Commun 332:853–858.
   PubMed Web of Science ®Google Scholar
• Fong, L. Y. Y., Jiang, Y. B., Farber, J. L. (2006). Zinc deficiency potentiates induction and progression of lingual and esophageal tumors in p53-deficient mice. Carcinogenesis 27:1489–1496.
   PubMed Web of Science ®Google Scholar
• Formigare, A., Irato, P., Santon, A. (2007a). Zinc, antioxidant systems, and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects. Comp Biochem Physiol C Toxicol Pharmacol 146:443–459.
   Google Scholar
• Formigari, A., Santon, A., Irato, P. (2007b). Efficacy of zinc treatment against iron-induced toxicity in rat hepatoma cell line H4-II-E-C3. Liver Int 27:120–127.
   PubMed Web of Science ®Google Scholar
• Franklin, R. B., Costello, L. C. (2007). Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys 463:211–217.
   PubMed Web of Science ®Google Scholar
• Franklin, R. B., Costello, L. C. (2009). The important role of the apoptotic effects of zinc in the development of cancers. J Cell Biochem 106:750–757.
   PubMed Web of Science ®Google Scholar
• Frederickson, C. J., Koh, J. Y., Bush, A I. (2005). The neurobiology of zinc in health and disease. Nat Rev Neurosci 6:449–462.
   PubMed Web of Science ®Google Scholar
• Fukada, T., Yamasaki, S., Nishida, K., Murakami, M., Hirano, T. (2011). Zinc homeostasis and signaling in health and diseases. J Biol Inorg Chem 16:1123–1134.
   PubMed Web of Science ®Google Scholar
• Futakawa, N., Kondoh, M., Ueda, S., Higashimoto, M., Takiguchi, M., Suzuki, S., et al. (2006). Involvement of oxidative stress in the synthesis of metallothionein induced by mitochondrial inhibitors. Biol Pharm Bull 29:2016–2020.
   PubMed Web of Science ®Google Scholar
• Ghoshal, K., Jacob, S. T. (2001). Regulation of metallothionein gene expression. Prog Nucleic Acid Res Mol Biol 66:357–384.
   PubMed Web of Science ®Google Scholar
• Ghoshal, K., Majumder, S., Jacob, S. T. (2002). Analysis of promoter methylation and its role in silencing metallothionein I gene expression in tumor cells. Redox Cell Biol Genetics Pt B 353:476–486.
   Web of Science ®Google Scholar
• Gomulkiewicz, A., Podhorska-Okolow, M., Szulc, R., Smorag, Z., Wojnar, A., Zabel, M., et al. (2010). Correlation between metallothionein (MT) expression and selected prognostic factors in ductal breast cancers. Folia Histochem Cytobiol 48:242–248.
   PubMed Web of Science ®Google Scholar
• Gosland, M., Lum, B., Schimmelpfennig, J., Baker, J., Doukas, M. (1996). Insights into mechanisms of cisplatin resistance and potential for its clinical reversal. Pharmacotherapy 16:16–39.
   PubMed Web of Science ®Google Scholar
• Grant, W. B. (2008). An ecological study of cancer mortality rates including indices for dietary iron and zinc. Anticancer Res 28:1955–1963.
   PubMed Web of Science ®Google Scholar
• Gumulec, J., Masarik, M., Krizkova, S., Adam, V., Hubalek, J., Hrabeta, J., et al. (2011). Insight to physiology and pathology of zinc(II) ions and their actions in breast and prostate carcinoma. Curr Med Chem 18:5041–5051.
   PubMed Web of Science ®Google Scholar
• Gunes, C., Heuchel, R., Georgiev, O., Muller, K. H., Lichtlen, P., Bluthmann, H., et al. (1998). Embryonic lethality and liver degeneration in mice lacking the metal-responsive transcriptional activator MTF-1. EMBO J 17:2846–2854.
   PubMed Web of Science ®Google Scholar
• Hafsi, H., Hainaut, P. (2011). Redox control and interplay between p53 isoforms: roles in the regulation of basal p53 levels, cell fate, and senescence. Antioxid Redox Signal 15:1655–1667.
   PubMed Web of Science ®Google Scholar
• Haga, A., Nagase, H., Kito, H., Sato, T. (1996). Effect of metallothioneins on collagenolytic activity of tumor gelatinase B. Cancer Res Ther Ctrl 5:17–22.
   Web of Science ®Google Scholar
• Haga, A., Nagase, H., Kito, H., Sato, T. (1997). Invasive properties of cadmium-resistant human fibrosarcoma HT-1080 cells. Cancer Biochem Biophys 15:275–284.
   PubMedGoogle Scholar
• Hainaut, P., Mann, K. (2001). Zinc binding and redox control of p53 structure and function. Antioxid Redox Signal 3:611–623.
   PubMed Web of Science ®Google Scholar
• Hao, Q., Maret, W. (2005). Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease. J Alzheimers Dis 8:161–170.
   PubMed Web of Science ®Google Scholar
• Ho, E. (2004). Zinc deficiency, DNA damage, and cancer risk. J Nutr Biochem 15:572–578.
   PubMed Web of Science ®Google Scholar
• Hogstrand, C., Kille, P., Nicholson, R. I., Taylor, K. M. (2009). Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation. Trends Mol Med 15:101–111.
   Google Scholar
• Huang, M., Shaw, C. F., Petering, D. H. (2004). Interprotein metal exchange between transcription factor IIIa and apo-metallothionein. J Inorg Biochem 98:639–648.
   PubMed Web of Science ®Google Scholar
• Huang, Z. X. (2010). Neuronal growth-inhibitory factor (metallothionein-3): a unique metalloprotein. FEBS J 277:2911.
   Web of Science ®Google Scholar
• Il’yasova, D., Schwartz, G. G. (2005). Cadmium and renal cancer. Toxicol Appl Pharmacol 207:179–186.
   PubMed Web of Science ®Google Scholar
• Iwata, M., Takebayashi, T., Ohta, H., Alcalde, R. E., Itano, Y., Matsumura, T. (1999). Zinc accumulation and metallothionein gene expression in the proliferating epidermis during wound healing in mouse skin. Histochem Cell Biol 112:283–290.
   PubMed Web of Science ®Google Scholar
• Jamieson, A. C., Miller, J. C., Pabo, C. O. (2003). Drug discovery with engineered zinc-finger proteins. Nat Rev Drug Discov 2:361–368.
   PubMed Web of Science ®Google Scholar
• Jasani, B., Schmid, K. W. (1997). Significance of metallothionein overexpression in human. Histopathology 31:211–214.
   PubMed Web of Science ®Google Scholar
• Jason, T. L. H., Koropatnick, J., Berg, R. W. (2004). Toxicology of antisense therapeutics. Toxicol Appl Pharmacol 201:66–83.
   PubMed Web of Science ®Google Scholar
• Jayasurya, A., Bay, B. H., Yap, W. M., Tan, N. G., Tan, B. K. H. (2000). Proliferative potential in nasopharyngeal carcinoma: correlations with metallothionein expression and tissue zinc levels. Carcinogenesis 21:1809–1812.
   PubMed Web of Science ®Google Scholar
• Jin, R. X., Huang, J. X., Tan, P. H., Bay, B. H. (2004). Clinicopathological significance of metallothioneins in breast cancer. Pathol Oncol Res 10:74–79.
   PubMed Web of Science ®Google Scholar
• Jin, R. X., Chow, V. T. K., Tan, P. H., Dheen, S. T., Duan, W., Bay, B. H. (2002). Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis 23:81–86.
   PubMed Web of Science ®Google Scholar
• John, E., Laskow, T. C., Buchser, W. J., Pitt, B. R., Basse, P. H., Butterfield, L. H., et al. (2010a). Zinc in innate and adaptive tumor immunity. J Transl Med 8:1–16.
   PubMedGoogle Scholar
• John, S., Briatka, T., Rudolf, E. (2010b). Diverse sensitivity of cells representing various stages of colon carcinogenesis to increased extracellular zinc: implications for zinc chemoprevention. Oncol Rep 25:769–780.
   PubMed Web of Science ®Google Scholar
• Kagi, J. H. R., Schaffer, A. (1988). Biochemistry of metallothionein. Biochemistry 27:8509–8515.
   PubMed Web of Science ®Google Scholar
• Kaibori, M., Sakitani, K., Oda, M., Kamiyama, Y., Masu, Y., Nishizawa, M., et al. (1999). Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-ÎşB activation in rat hepatocytes. J Hepatol 30:1138–1145.
   PubMed Web of Science ®Google Scholar
• Karasawa, M., Nishimura, N., Nishimura, H., Tohyama, C., Hashiba, H., Kuroki, T. (1991). Localization of metallothionein in hair-follicles of normal skin and the basal-cell layer of hyperplastic epidermis—possible association with cell-proliferation. J Invest Dermatol 97:97–100.
   PubMed Web of Science ®Google Scholar
• Karin, M., Eddy, R. L., Henry, W. M., Haley, L. L., Byers, M. G., Shows, T. B. (1984). Human metallothionein genes are clustered on chromosome-16. Proc Natl Acad Sci U S A 81:5494–5498.
   PubMed Web of Science ®Google Scholar
• Kennette, W., Collins, O. M., Zalups, R. K., Koropatnick, J. (2005). Basal and zinc-induced metallothionein in resistance to cadmium, cisplatin, zinc, and tertButyl hydroperoxide: studies using MT knockout and antisense-downregulated MT in mammalian cells. Toxicol Sci 88:602–613.
   PubMed Web of Science ®Google Scholar
• Kim, H. G., Kim, J. Y., Han, E. H., Hwang, Y. P., Choi, J. H., Park, B. H., et al. (2011). Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells. FEBS Lett 585:421–428.
   PubMed Web of Science ®Google Scholar
• Kim, C. H., Kim, J. H., Lee, J., Ahn, Y. S. (2003). Zinc-induced NF-kappa B inhibition can be modulated by changes in the intracellular metallothionein level. Toxicol Appl Pharmacol 190:189–196.
   PubMed Web of Science ®Google Scholar
• Kimura, T. (2010). Molecular mechanisms of zinc-mediated induction and chromium(VI)-mediated inhibition of mouse metallothionein-I gene transcription. J Health Sci 56:161–166.
   Web of Science ®Google Scholar
• Klaassen, C. D., Choudhuri, S., McKim, J. M., Lehmanmckeeman, L. D., Kershaw, W. C. (1994). In-vitro and in-vivo studies on the degradation of metallothionein. Environ Health Perspect 102:141–146.
   PubMed Web of Science ®Google Scholar
• Klaassen, C. D., Liu, J., Diwan, B. A. (2009). Metallothionein protection of cadmium toxicity. Toxicol Appl Pharmacol 238:215–220.
   PubMed Web of Science ®Google Scholar
• Klassen, R. B., Crenshaw, K., Kozyraki, R., Verroust, P. J., Tio, L., Atrian, S., et al. (2004). Megalin mediates renal uptake of heavy metal metallothionein complexes. Am J Physiol Renal Physiol 287:F393–F403.
   PubMed Web of Science ®Google Scholar
• Knipp, M. (2009). Metallothioneins and platinum(II) anti-tumor compounds. Curr Med Chem 16:522–537.
   PubMed Web of Science ®Google Scholar
• Knipp, M., Meloni, G., Roschitzki, B., Vasak, M. (2005). Zn(7)metallothionein-3 and the synaptic vesicle cycle: interaction of metallothionein-3 with the small GTPase Rab3A. Biochemistry 44:3159–3165.
   PubMed Web of Science ®Google Scholar
• Ko, Y. H., Woo, Y. J., Kim, J. W., Choi, H., Kang, S. H., Lee, J. G., et al. (2010). High-dose dietary zinc promotes prostate intraepithelial neoplasia in a murine tumor induction model. Asian J Androl 12:164–170.
   PubMed Web of Science ®Google Scholar
• Koizumi, S., Yamada, H. (2003). DNA microarray analysis of altered gene expression in cadmium-exposed human cells. J Occup Health 45:331–334.
   PubMed Web of Science ®Google Scholar
• Kondo, Y., Rusnak, J. M., Hoyt, D. G., Settineri, C. E., Pitt, B. R., Lazo, J. S. (1997). Enhanced apoptosis in metallothionein null cells. Mol Pharmacol 52:195–201.
   PubMed Web of Science ®Google Scholar
• Kothinti, R., Blodgett, A., Tabatabai, N. M., Petering, D. H. (2010). Zinc finger transcription factor Zn(3)-SP1 reactions with Cd(2+). Chem Res Toxicol 23:405–412.
   PubMed Web of Science ®Google Scholar
• Krejcova, L., Fabrik, I., Hynek, D., Krizkova, S., Gumulec, J., Ryvolova, M., et al. (2012). Metallothionein electrochemically determined using Brdicka reaction as a promising blood marker of head and neck malignant tumours. Int J Electrochem Sci 7:1767–1784.
   Web of Science ®Google Scholar
• Krezel, A., Maret, W. G. (2008). Thionein/metallothionein control Zn(II) availability and the activity of enzymes. J Biol Inorg Chem 13:401–409.
   PubMed Web of Science ®Google Scholar
• Krizkova, S., Fabrik, I., Adam, V., Hrabeta, P., Eckschlager, T., Kizek, R. (2009). Metallothionein—a promising tool for cancer diagnostics. Bratisl Med J 110:93–97.
   Web of Science ®Google Scholar
• Krizkova, S., Fabrik, I., Adam, V., Kukacka, J., Prusa, R., Chavis, G. J., et al. (2008). Utilizing of adsorptive transfer stripping technique Brdicka reaction for determination of metallothioneins level in melanoma cells, blood serum, and tissues. Sensors 8:3106–3122.
   Web of Science ®Google Scholar
• Krizkova, S., Masarik, M., Majzlik, P., Kukacka, J., Kruseova, J., Adam, V., et al. (2010). Serum metallothionein in newly diagnosed patients with childhood solid tumours. Acta Biochim Pol 57:561–566.
   PubMed Web of Science ®Google Scholar
• Krizkova, S., Ryvolova, M., Gumulec, J., Masarik, M., Adam, V., Majzlik, P., et al. (2011). Electrophoretic fingerprint metallothionein analysis as a potential prostate cancer biomarker. Electrophoresis 32:1952–1961.
   PubMed Web of Science ®Google Scholar
• Krizkova, S., Ryvolova, M., Hynek, D., Eckschlager, T., Hodek, P., Masarik, M., et al. (2012). Immunoextraction of zinc proteins from human plasma using chicken yolk antibodies immobilized onto paramagnetic particles and their electrophoretic analysis. Electrophoresis 2012;33:1824–1832.
   PubMed Web of Science ®Google Scholar
• Krolicka, A., Kobierzycki, C., Pula, B., Podhorska-Okolow, M., Piotrowska, A., Rzeszutko, M., et al. (2010). Comparison of metallothionein (MT) and Ki-67 antigen expression in benign and malignant thyroid tumours. Anticancer Res 30:4945–4949.
   PubMed Web of Science ®Google Scholar
• Kroncke, K. D. (2001). Zinc finger proteins as molecular targets for nitric oxide-mediated gene regulation. Antioxid Redox Signal 3:565–575.
   PubMed Web of Science ®Google Scholar
• Kroncke, K. D., Fehsel, K., Schmidt, T., Zenke, F. T., Dasting, I., Wesener, J. R., et al. (1994). Nitric-oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator lac9. Biochem Biophys Res Commun 200:1105–1110.
   PubMed Web of Science ®Google Scholar
• Kuppens, K., De Ley, M. (2006). Serum-induced expression of metallothionein isoforms in K-562 cells. Biochem Biophys Res Commun 342:979–983.
   PubMed Web of Science ®Google Scholar
• Kuroda, S., Tokunaga, C., Kiyohara, Y., Higuchi, O., Konishi, H., Mizuno, K., et al. (1996). Protein-protein interaction of zinc finger LIM domains with protein kinase C. J Biol Chem 271:31029–31032.
   PubMed Web of Science ®Google Scholar
• Lai, Y. Y., Lim, D. N., Tan, P. H., Leung, T. K. C., Yip, G. W. C., Bay, B. H. (2010). Silencing the metallothionein-2A gene induces entosis in adherent MCF-7 breast cancer cells. Anat Rec 293:1685–1691.
   Google Scholar
• Lai, Y. Y., Yip, G. W. C., Bay, B. H. (2011). Targeting metallothionein for prognosis and treatment of breast cancer. Recent Pat Anticancer Drug Discov 6:178–185.
   Google Scholar
• Lee, S. J., Park, M. H., Kim, H. J., Koh, J. Y. (2010). Metallothionein-3 regulates lysosomal function in cultured astrocytes under both normal and oxidative conditions. Glia, 58, 1186–96.
   PubMed Web of Science ®Google Scholar
• Lee, Y. C., Wang, H. P., Wang, C. P., Ko, J. Y., Lee, J. M., Chiu, H. M., et al. (2011). Revisit of field cancerization in squamous cell carcinoma of upper aerodigestive tract: better risk assessment with epigenetic markers. Cancer Prev Res 4:1982–1992.
   PubMed Web of Science ®Google Scholar
• Lindeque, J. Z., Levanets, O., Louw, R., Van Der Westhuizen, F. H. (2010). The involvement of metallothioneins in mitochondrial function and disease. Curr Protein Pept Sci 11:292–309.
   PubMed Web of Science ®Google Scholar
• Liu, J., Qu, W., Kadiiska, M. B. (2009). Role of oxidative stress in cadmium toxicity and carcinogenesis. Toxicol Appl Pharmacol 238:209–214.
   PubMed Web of Science ®Google Scholar
• Luparello, C., Sirchia, R., Longo, A. (2011). Cadmium as a transcriptional modulator in human cells. Crit Rev Toxicol 41:73–80.
   Web of Science ®Google Scholar
• Lynes, M. A., Borghesi, L. A., Youn, J. H., Olson, E. A. (1993). Immunomodulatory activities of extracellular metallothionein. 1. Metallothionein effects on antibody-production. Toxicology 85:161–177.
   PubMed Web of Science ®Google Scholar
• Lynes, M. A., Zaffuto, K., Unfricht, D. W., Marusov, G., Samson, J. S., Yin, X. Y. (2006). The physiological roles of extracellular metallothionein. Exp Biol Med 231:1548–1554.
   Web of Science ®Google Scholar
• Malgieri, G., Zaccaro, L., Leone, M., Bucci, E., Esposito, S., Baglivo, I., et al. (2011). Zinc to cadmium replacement in the A. thaliana SUPERMAN Cys(2)His(2) zinc finger induces structural rearrangements of typical DNA base determinant positions. Biopolymers 95:801–810.
   PubMed Web of Science ®Google Scholar
• Malvy, D. J. M., Arnaud, J., Burtschy, B., Sommelet, D., Leverger, G., Dostalova, L., et al. (1997). Antioxidant micronutrients and childhood malignancy during oncological treatment. Med Pediatric Oncol 29:213–217.
   PubMedGoogle Scholar
• Malvy, D. J. M., Burtschy, B., Arnaud, J., Sommelet, D., Leverger, G., Dostalova, L., et al. (1993). Serum beta-carotene and antioxidant micronutrients in children with cancer. Int J Epidemiol 22:761–771.
   PubMed Web of Science ®Google Scholar
• Maret, W. (2005). Zinc coordination environments in proteins determine zinc functions. J Trace Elem Med Biol 19:7–12.
   PubMed Web of Science ®Google Scholar
• Maret, W., Jacob, C., Vallee, B. L., Fischer, E. H. (1999). Inhibitory sites in enzymes: zinc removal and reactivation by thionein. Proc Natl Acad Sci U S A 96:1936–1940.
   PubMed Web of Science ®Google Scholar
• Maret, W., Krezel, A. (2007). Cellular zinc and redox buffering capacity of metallthionein/thionein in health and disease. Mol Med 13:371–375.
   PubMed Web of Science ®Google Scholar
• Maret, W., Yetman, C. A., Jiang, L. J. (2001). Enzyme regulation by reversible zinc inhibition: glycerol phosphate dehydrogenase as an example. Chem Biol Interact 130:891–901.
   PubMed Web of Science ®Google Scholar
• Margoshes, M., Vallee, B. L. (1957). A cadmium protein from equine kidney cortex. J Am Chem Soc 79:4813–4814.
   Web of Science ®Google Scholar
• Masarik, M, Gumulec, J, Sztalmachova, M, Hlavna, M, Babula, P, Krizkova, S, et al. (2011). Isolation of metallothionein from cells derived from aggressive form of high-grade prostate carcinoma using paramagnetic antibody-modified microbeads off-line coupled with electrochemical and electrophoretic analysis. Electrophoresis 32:3576–3588.
   PubMed Web of Science ®Google Scholar
• McGee, H. M., Woods, G. M., Bennett, B., Chung, R. S. (2010). The two faces of metallothionein in carcinogenesis: photoprotection against UVR-induced cancer and promotion of tumour survival. Photochem Photobiol Sci 9:586–596.
   PubMed Web of Science ®Google Scholar
• McKim, J. M., Jr., Choudhuri, S., Klaassen, C. D. (1992). In vitro degradation of apo-metallothionein, zinc-metallothionein, and cadmium-metallothionein by cathepsin B, cathepsin C, and cathepsin D. Toxicol Appl Pharmacol 116:117–124.
   PubMed Web of Science ®Google Scholar
• Meplan, C., Hainaut, P. (1999). Molecular alchemy of the tumor suppressor protein p53: metals and cell growth control. J Trace Elem Med Biol 12:337–346.
   Web of Science ®Google Scholar
• Meplan, C., Richard, M. J., Hainaut, P. (2000). Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 19:5227–5236.
   PubMed Web of Science ®Google Scholar
• Miles, A. T., Hawksworth, G. M., Beattie, J. H., Rodilla, V. (2000). Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol 35:35–70.
   PubMed Web of Science ®Google Scholar
• Mocchegiani, E., Muzzioli, M., Giacconi, R. (2000). Zinc, metallothioneins, immune responses, survival, and ageing. Biogerontology 1:133–143.
   PubMed Web of Science ®Google Scholar
• Morellini, N. M., Giles, N. L., Rea, S., Adcroft, K. F., Falder, S., King, C. E., et al. (2008). Exogenous metallothionein-IIA promotes accelerated healing after a burn wound. Wound Repair Regen 16:682–690.
   PubMed Web of Science ®Google Scholar
• Müller, J. (2010). Functional metal ions in nucleic acids. Metallomics 2:318–327.
   PubMed Web of Science ®Google Scholar
• Murakami, M., Hirano, T. (2008). Intracellular zinc homeostasis and zinc signaling. Cancer Sci 99:1515–1522.
   PubMed Web of Science ®Google Scholar
• Nagano, T., Itoh, N., Ebisutani, C., Takatani, T., Miyoshi, T., Nakanishi, T., et al. (2000). The transport mechanism of metallothionein is different from that of classical NLS-bearing protein. J Cell Physiol 185:440–446.
   PubMed Web of Science ®Google Scholar
• Nagel, W. W., Vallee, B. L. (1995). Cell-cycle regulation of metallothionein in human-colonic cancer cells. Proc Natl Acad Sci U S A 92:579–583.
   PubMed Web of Science ®Google Scholar
• Naito, S., Yokomizo, A., Koga, H. (1999). Mechanisms of drug resistance in chemotherapy for urogenital carcinoma. Int J Urol 6:427–439.
   PubMed Web of Science ®Google Scholar
• Namdarghanbari, M., Wobig, W., Krezoski, S., Tabatabai, N. M., Petering, D. H. (2011). Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy. J Biol Inorg Chem 16:1087–1101.
   PubMed Web of Science ®Google Scholar
• Nartey, N., Cherian, M. G., Banerjee, D. (1987). Immunohistochemical localization of metallothionein in human thyroid-tumors. Am J Pathol 129:177–182.
   PubMed Web of Science ®Google Scholar
• Nzengue, Y., Lefebvre, E., Cadet, J., Favier, A., Rachidi, W., Steiman, R., et al. (2009). Metallothionein expression in HaCaT and C6 cell lines exposed to cadmium. J Trace Elem Med Biol 23:314–323.
   PubMed Web of Science ®Google Scholar
• Ogra, Y., Suzuki, K. T. (2000). Nuclear trafficking of metallothionein: possible mechanisms and current knowledge. Cell Mol Biol 46:357–365.
   PubMed Web of Science ®Google Scholar
• Olesen, C., Moller, M., Byskov, A. G. (2004). Tesmin transcription is regulated differently during male and female meiosis. Mol Reprod Dev 67:116–126.
   PubMed Web of Science ®Google Scholar
• Ostrakhovitch, E. A. (2011). Redox environment and its meaning for breast cancer cells fate. Curr Cancer Drug Targets 11:479–495.
   PubMed Web of Science ®Google Scholar
• Ostrakhovitch, E. A., Olsson, P. E., Jiang, S., Cherian, M. G. (2006). Interaction of metallothionein with tumor suppressor p53 protein. FEBS Lett 580:1235–1238.
   PubMed Web of Science ®Google Scholar
• Ostrakhovitch, E. A., Olsson, P. E., Von Hofsten, J., Cherian, M. G. (2007). p53 mediated regulation of metallothionen transcription in breast cancer cells. J Cell Biochem 102:1571–1583.
   PubMed Web of Science ®Google Scholar
• Oyama, T., Takei, H., Hikino, T., Iino, Y., Nakajima, T. (1996). Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. Oncology 53:112–117.
   PubMed Web of Science ®Google Scholar
• Palecek, E., Brazdova, M., Cernocka, H., Vlk, D., Brazda, V., Vojtesek, B. (1999). Effect of transition metals on binding of p53 protein to supercoiled DNA and to consensus sequence in DNA fragments. Oncogene 18:3617–3625.
   PubMed Web of Science ®Google Scholar
• Papouli, E., Defais, M., Larminat, F. (2002). Overexpression of metallothionein-II sensitizes rodent cells to apoptosis induced by DNA cross-linking agent through inhibition of NF-kappa B activation. J Biol Chem 277:4764–4769.
   PubMed Web of Science ®Google Scholar
• Pedersen, M. O., Larsen, A., Stoltenberg, M., Penkowa, M. (2009). The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem 44:29–64.
   PubMed Web of Science ®Google Scholar
• Perez, R. P. (1998). Cellular and molecular determinants of cisplatin resistance. Eur J Cancer 34:1535–1542.
   PubMed Web of Science ®Google Scholar
• Plum, L. M., Rink, L., Haase, H. (2010). The essential toxin: impact of zinc on human health. Int J Environ Res Public Health 7:1342–1365.
   PubMed Web of Science ®Google Scholar
• Porteus, M. H., Carroll, D. (2005). Gene targeting using zinc finger nucleases. Nat Biotechnol 23:967–973.
   PubMed Web of Science ®Google Scholar
• Prasad, A. S., Kucuk, O. (2002). Zinc in cancer prevention. Cancer Metastasis Rev 21:291–295.
   PubMed Web of Science ®Google Scholar
• Provinciali, M., Donnini, A., Argentati, K., Di Stasio, G., Bartozzi, B., Bernardini, G. (2002). Reactive oxygen species modulate Zn2+-induced apoptosis in cancer cells. Free Radic Biol Med 32:431–445.
   PubMed Web of Science ®Google Scholar
• Rao, P. S., Jaggi, M., Smith, D. J., Hemstreet, G. P., Balaji, K. C. (2003). Metallothionein 2A interacts with the kinase domain of PKC mu in prostate cancer. Biochem Biophys Res Commun 310:1032–1038.
   PubMed Web of Science ®Google Scholar
• Ribeiro, A. L. R., Nobre, R. M., Rocha, G., Lobato, I. H. D., Alves, S. D., Jaeger, R. G., et al. (2011). Expression of metallothionein in ameloblastoma. A regulatory molecule? J Oral Pathol Med 40:516–519.
   PubMed Web of Science ®Google Scholar
• Rickert, C. H. (2004). Prognosis-related molecular markers in pediatric central nervous system tumors. J Neuropathol Exp Neurol 63:1211–1224.
   PubMed Web of Science ®Google Scholar
• Rickert, C. H., Paulus, W. (2005). Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors of childhood and adolescence. Acta Neuropathol 109:69–92.
   PubMed Web of Science ®Google Scholar
• Roesijadi, G., Bogumil, R., Vasak, M., Kagi, J. H. R. (1998). Modulation of DNA binding of a tramtrack zinc finger peptide by the metallothionein-thionein conjugate pair. J Biol Chem 273:17425–17432.
   PubMed Web of Science ®Google Scholar
• Rossen, K., Haerslev, T., Houjensen, K., Jacobsen, G. K. (1997). Metallothionein expression in basaloid proliferations overlying dermatofibromas and in basal cell carcinomas. Br J Dermatol 136:30–34.
   PubMed Web of Science ®Google Scholar
• Ryu, M. S., Langkamp-Henken, B., Chang, S. M., Shankar, M. N., Cousins, R. J. (2011). Genomic analysis, cytokine expression, and microRNA profiling reveal biomarkers of human dietary zinc depletion and homeostasis. Proc Natl Acad Sci U S A 108:20970–20975.
   Google Scholar
• Sato, M., Bremner, I. (1993). Oxygen free-radicals and metallothionein. Free Radic Biol Med 14:325–337.
   PubMed Web of Science ®Google Scholar
• Scanlon, K. J., Kashanisabet, M., Tone, T., Funato, T. (1991). Cisplatin resistance in human cancers. Pharmacol Ther 52:385–406.
   PubMed Web of Science ®Google Scholar
• Searle, P. F., Stuart, G. W., Palmiter, R. D. (1985). Building a metal-responsive promoter with synthetic regulatory elements. Mol Cell Biol 5:1480–1489.
   PubMed Web of Science ®Google Scholar
• Seo, Y. R., Kim, B. J., Ryu, J. C. (2005). Molecular and genomic approaches on nickel toxicity and carcinogenicity. Mol Cell Toxicol 1:73–77.
   Web of Science ®Google Scholar
• Shami, P. J., Moore, J. O., Gockerman, J. P., Hathorn, J. W., Misukonis, M. A., Weinberg, J. B. (1995). Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells. Leuk Res 19:527–533.
   PubMed Web of Science ®Google Scholar
• Shi, Y. B., Du, L., Zheng, W. J., Tang, W. X. (2002). Isolation of GIF from porcine brain and studies of its zinc transfer kinetics with apo-carbonic anhydrase. Biometals 15:421–427.
   PubMed Web of Science ®Google Scholar
• Shi, Y. H., Amin, K., Sato, B. G., Samuelsson, S. J., Sambucetti, L., Haroon, Z. A., et al. (2010). The metal-responsive transcription factor-1 protein is elevated in human tumors. Cancer Biol Ther 9:8.
   Web of Science ®Google Scholar
• Simpkins, C., Lloyd, T., Li, S., Balderman, S. (1998). Metallothionein-induced increase in mitochondrial inner membrane permeability. J Surg Res 75:30–34.
   PubMed Web of Science ®Google Scholar
• Simpkins, C. O. (2000). Metallothionein in human disease. Cell Mol Biol 46:465–488.
   PubMed Web of Science ®Google Scholar
• Sliwinska-Mosson, M., Milnerowicz, H., Rabczynski, J., Milnerowicz, S. (2009). Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas. Arch Immunol Ther Exp 57:295–301.
   PubMed Web of Science ®Google Scholar
• Sochor, J., Hynek, D., Krejcova, L., Fabrik, I., Krizkova, S., Gumulec, J., et al. (2012). Study of metallothionein role in spinocellular carcinoma tissues of head and neck tumours using Brdicka reaction. Int J Electrochem Sci 7:2136–2152.
   Web of Science ®Google Scholar
• Soo, E. T. L., Ng, C. T., Yip, G. W. C., Koo, C. Y., Nga, M. E., Tan, P. H., et al. (2011). Differential expression of metallothionein in gastrointestinal stromal tumors and gastric carcinomas. Anat Rec 294:267–272.
   Google Scholar
• St Croix, C. M., Wasserloos, K. J., Dineley, K. E., Reynolds, I. J., Levitan, E. S., Pitt, B. R. (2002). Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein. Am J Physiol Lung Cell Mol Physiol 282:L185–L192.
   PubMed Web of Science ®Google Scholar
• Sugiura, T., Yamashita, U. (2000). B cell stimulating activity of metallothionein in vitro. Int J Immunopharmacol 22:113–122.
   PubMed Web of Science ®Google Scholar
• Suzuki, S., Tohma, S., Futakawa, N., Higashimoto, M., Takiguchi, M., Sato, M. (2005). Induction of hepatic metallothionein by mitochondrial oxidative stress in mice. J Health Sci 51:533–537.
   Web of Science ®Google Scholar
• Takahashi, Y., Ogra, Y., Suzuki, K. T. (2005). Nuclear trafficking of metallothionein requires oxidation of a cytosolic partner. J Cell Physiol 202:563–569.
   PubMed Web of Science ®Google Scholar
• Takeda, A., Hisada, H., Okada, S., Mata, J. E., Ebadi, M., Iversen, P. L. (1997). Tumor cell growth is inhibited by suppressing metallothionein-I synthesis. Cancer Lett 116:145–149.
   PubMed Web of Science ®Google Scholar
• Tan, O. J. K., Bay, B. H., Chow, V. T. K. (2005). Differential expression of metallothionein isoforms in nasopharyneal cancer and inhibition of cell growth by antisense down-regulation of metallothionein-2A. Oncol Rep 13:127–131.
   PubMed Web of Science ®Google Scholar
• Tarapore, P., Shu, Y., Guo, P. X., Ho, S. M. (2011). Application of Phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancers. Mol Ther 19:386–394.
   PubMed Web of Science ®Google Scholar
• Theocharis, S, Klijanienko, J, Giaginis, C, Rodriguez, J, Jouffroy, T, Girod, A, et al. (2011). Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival. Histopathology 59:514–525.
   PubMed Web of Science ®Google Scholar
• Theocharis, S. E., Margeli, A. P., Klijanienko, J. T., Kouraklis, G. P. (2004). Metallothionein expression in human neoplasia. Histopathology 45:103–118.
   PubMed Web of Science ®Google Scholar
• Theocharis, S. E., Margeli, A. P., Koutselinis, A. (2003). Metallothionein: a multifunctional protein from toxicity to cancer. Int J Biol Markers 18:162–169.
   PubMed Web of Science ®Google Scholar
• Thirumoorthy, N., Kumar, K. T. M., Sundar, A. S., Panayappan, L., Chatterjee, M. (2007). Metallothionein: an overview. World J Gastroenterol 13:993–996.
   PubMed Web of Science ®Google Scholar
• Thirumoorthy, N., Sunder, A. S., Kumar, K. T. M., Kumar, M. S., Ganesh, G. N. K., Chatterjee, M. (2011). A review of metallothionein isoforms and their role in pathophysiology. World J Surg Oncol 9:7.
   PubMed Web of Science ®Google Scholar
• Toh, P. P. C., Li, J. J., Yip, G. W. C., Lo, S. L., Guo, C. H., Phan, T. T., et al. (2010). Modulation of metallothionein isoforms is associated with collagen deposition in proliferating keloid fibroblasts in vitro. Exp Dermatol 19:987–993.
   PubMed Web of Science ®Google Scholar
• Tomita, T. (2002). New markers for pancreatic islets and islet cell tumors. Pathol Int 52:425–432.
   PubMed Web of Science ®Google Scholar
• Trieb, K., Kotz, R. (2001). Proteins expressed in osteosarcoma and serum levels as prognostic factors. Int J Biochem Cell Biol 33:11–17.
   PubMed Web of Science ®Google Scholar
• Tsujikawa, K., Imai, T., Kakutani, M., Kayamori, Y., Mimura, T., Otaki, N., et al. (1991). Localization of metallothionein in nuclei of growing primary cultured adult-rat hepatocytes. FEBS Lett 283:239–242.
   PubMed Web of Science ®Google Scholar
• Unal, E., Cavdar, A. O., Babacan, E., Gozdasoglu, S., Yavuz, G., Ikinciogullari, A., et al. (2001). Zinc status and cytokine profile in pediatric Hodgkin’s disease. J Trace Elem Med Biol 14:25–30.
   Web of Science ®Google Scholar
• Vallee, B. L., Coleman, J. E., Auld, D. S. (1991). Zinc fingers, zinc clusters, and zinc twists in DNA-binding protein domains. Proc Natl Acad Sci U S A 88:999–1003.
   PubMed Web of Science ®Google Scholar
• Vasak, M., Meloni, G. (2011). Chemistry and biology of mammalian metallothioneins. J Biol Inorg Chem 16:1067–1078.
   PubMed Web of Science ®Google Scholar
• Volm, M. (1998). Multidrug resistance and its reversal. Anticancer Res 18:2905–2917.
   PubMed Web of Science ®Google Scholar
• Vural, S. A., Vural, M. R., Kuplulu, S., Alcigir, M. E., Kaymaz, M. (2009). Immunohistochemical demonstration of p53 protein and metallothioneins in canine mammary tumours. Rev Med Vet 160:300–307.
   Google Scholar
• Waalkes, M. P., Rehm, S. (1994). Cadmium and prostate cancer. J Toxicol Environ Health 43:251–269.
   PubMed Web of Science ®Google Scholar
• Waisberg, M., Joseph, P., Hale, B., Beyersmann, D. (2003). Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192:95–117.
   PubMed Web of Science ®Google Scholar
• Wang, C. Y., Cusack, J. C., Liu, R., Baldwin, A S. (1999). Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappa B. Nat Med 5:412–417.
   PubMed Web of Science ®Google Scholar
• Wang, J. X., Yang, J. L. (2010). Interaction of tumor suppressor p53 with DNA and proteins. Curr Pharm Biotechnol 11:122–127.
   PubMed Web of Science ®Google Scholar
• Wlostowski, T. (1993). Involvement of metallothionein and copper in cell-proliferation. Biometals 6:71–76.
   PubMed Web of Science ®Google Scholar
• Woolston, C. M., Deen, S., Al-Attar, A., Shehata, M., Chan, S. Y., Martin, S. G. (2010). Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy. Free Radic Biol Med 49:1263–1272.
   PubMed Web of Science ®Google Scholar
• Xia, N., Liu, L., Yi, X. Y., Wang, J. X. (2009). Studies of interaction of tumor suppressor p53 with apo-MT using surface plasmon resonance. Anal Bioanal Chem 395:2569–2575.
   PubMed Web of Science ®Google Scholar
• Ye, B., Maret, W., Vallee, B. L. (2001). Zinc metallothionein imported into liver mitochondria modulates respiration. Proc Natl Acad Sci U S A 98:2317–2322.
   PubMed Web of Science ®Google Scholar
• Yin, X. Y., Knecht, D. A., Lynes, M. A. (2005). Metallothionein mediates leukocyte chemotaxis. BMC Immunol 6:1–12.
   PubMedGoogle Scholar
• Youn, J., Borghesi, L. A., Olson, E. A., Lynes, M. A. (1995). Immunomodulatory activities of extracellular metallothionein. 2. Effect on macrophage functions. J Toxicol Environ Health 45:397–413.
   PubMed Web of Science ®Google Scholar
• Youn, J., Lynes, M. A. (1999). Metallothionein-induced suppression of cytotoxic T lymphocyte function: an important immunoregulatory control. Toxicol Sci 52:199–208.
   PubMed Web of Science ®Google Scholar
• Zeng, J., Vallee, B. L., Kagi, J. H. R. (1991). Zinc transfer from transcription factor-IIIa fingers to thionein clusters. Proc Natl Acad Sci U S A 88:9984–9988.
   PubMed Web of Science ®Google Scholar
• Zitka, O., Kukacka, J., Krizkova, S., Huska, D., Adam, V., Masarik, M., et al. (2010). Matrix metalloproteinases. Curr Med Chem, 17, 3751–68.
   PubMed Web of Science ®Google Scholar
• Zuo, X. L., Chen, J. M., Zhou, X., Li, X. Z., Mei, G. Y. (2006). Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res, 114, 41–53.
   PubMed Web of Science ®Google Scholar